Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001643127-25-000006
Filing Date
2025-11-03
Accepted
2025-11-03 16:32:02
Documents
1
Period of Report
2025-08-11

Document Format Files

Seq Description Document Type Size
1 form4-11032025_091158.html 4  
1 form4-11032025_091158.xml 4 4267
  Complete submission text file 0001643127-25-000006.txt   5815
Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Issuer) CIK: 0001401040 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AMAG PHARMACEUTICALS, INC. 1100 WINTER STREET WALTHAM MA 02451
Business Address
Krop Julie (Reporting) CIK: 0001643127 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36291 | Film No.: 251444622